/Abstract 1656: ISM6331, a novel and potent pan-TEAD inhibitor, exhibits strong anti-tumor activity in preclinical models of Hippo pathway-dysregulated cancers
Citation Map
The articles shown here are a subset.See the full list of articles below.
Citing (0)
Citation Count
Data not found
Cited By (0)
Citation Count